186 related articles for article (PubMed ID: 16164742)
1. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.
Chintamani ; Singh JP; Mittal MK; Saxena S; Bansal A; Bhatia A; Kulshreshtha P
World J Surg Oncol; 2005 Sep; 3():61. PubMed ID: 16164742
[TBL] [Abstract][Full Text] [Related]
2. Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.
Chintamani ; Singhal V; Singh JP; Lyall A; Saxena S; Bansal A
BMC Cancer; 2004 Aug; 4():48. PubMed ID: 15310398
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Vishnukumar S; Umamaheswaran G; Anichavezhi D; Indumathy S; Adithan C; Srinivasan K; Kadambari D
Indian J Cancer; 2013; 50(3):195-9. PubMed ID: 24061458
[TBL] [Abstract][Full Text] [Related]
4. P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy-a Prospective Clinical Study from a Developing Country.
Mehrotra M; Anand A; Singh KR; Kumar S; Husain N; Sonkar AA
Indian J Surg Oncol; 2018 Dec; 9(4):524-529. PubMed ID: 30538383
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
6. The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer.
Chintamani ; Jha BP; Bhandari V; Bansal A; Saxena S; Bhatnagar D
Int Semin Surg Oncol; 2007 Feb; 4():5. PubMed ID: 17394628
[TBL] [Abstract][Full Text] [Related]
7. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
9. Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance.
Xiang F; Yu W; Shen Y; Wu C; Wang Y
Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):398-405. PubMed ID: 21126409
[TBL] [Abstract][Full Text] [Related]
10. Role of
Moulika JS; Kalawat T; Manthri RG; Hulikal N; Kadiyala S; Bhargavi D; Prayaga AK
Indian J Nucl Med; 2023; 38(4):354-361. PubMed ID: 38390549
[TBL] [Abstract][Full Text] [Related]
11. Breast conservative surgery: is it appropriate for locally advanced breast cancer following downstaging by neoadjuvant chemotherapy? A pathological assessment.
Moneer M; El-Didi M; Khaled H
Breast; 1999 Dec; 8(6):315-9. PubMed ID: 14731459
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor predicts response to chemotherapy in esophageal cancer.
Motoori M; Yano M; Tomita Y; Takahashi H; Tanaka K; Sugimura K; Kishi K; Fujiwara Y; Miyoshi N; Akita H; Goto K; Marubashi S; Noura S; Ohue M; Ishikawa O; Sakon M
J Surg Res; 2014 Sep; 191(1):99-105. PubMed ID: 24755284
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant induction chemotherapy.
Schwartz G
Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Carcinoma Using Image-Guided Clip Placement.
Pandurangappa V; Paruthy SB; Jamwal R; Singh A; Tanwar S; Kumar D; Pal S; Mohan SK; Das A; Trs PR
Cureus; 2023 Oct; 15(10):e47763. PubMed ID: 38021852
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
Sharma A; Grover SB; Mani C; Ahluwalia C
Br J Radiol; 2021 May; 94(1121):20201160. PubMed ID: 33860674
[TBL] [Abstract][Full Text] [Related]
17. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?
Dave S; Choudhury A; Alurkar SS; Shah AM
Indian J Surg Oncol; 2024 Mar; 15(1):44-52. PubMed ID: 38511030
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
[TBL] [Abstract][Full Text] [Related]
19. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer.
Chung HC; Gong SJ; Yoo NC; Noh SH; Kim JH; Roh JK; Min JS; Kim BS; Lee KB
Yonsei Med J; 1996 Dec; 37(6):397-404. PubMed ID: 9048492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
